• See More.
    Care Better.

    Enhance your practice with the
    hassle-free CapsoCam® Plus System


Latest News

  • CapsoVision, Inc. Announces FDA 510(k) Clearance for CapsoCam® SV-1

    March 4, 2016
    CapsoVision is pleased to announce it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for CapsoCam® SV-1. The clinical study submitted to the FDA was designed to demonstrate that CapsoCam SV-1 is safe and effective for the intended use of visualization of the small bowel mucosa in adults, and it may be used as a tool in the detection of abnormalities of the small bowel  The study compared CapsoCam SV-1 to PillCam® SB2. Results from the multi-center study demonstrate that CapsoCam SV-1 performs in a manner that is substantially equivalent to PillCam SB2 and has a comparable safety profile as PillCam SB2. In a patient questionnaire administered during the study, ~80% patients indicated that they preferred the CapsoCam system to the PillCam system.
  • CapsoVision Announces Availability of Next Generation CapsoCam Plus System

    February 29, 2016

    SARATOGA, Calif. - February 29, 2016 - CapsoVision, Inc., a Silicon Valley medical device innovator, announces availability of their next generation small bowel capsule endoscopy solution, The CapsoCam® Plus System.

    The CapsoCam Plus System consists of a capsule endoscope, a retrieval kit, a data access system, and software, which work together to provide a streamlined, patient-friendly examination with no capital investment required.